A serological assay to detect SARS-CoV-2 seroconversion in humans

Fatima Amanat; Daniel Stadlbauer; Shirin Strohmeier; Thi Nguyen; Veronika Chromikova; Meagan McMahon; Kaijun Jiang; Guha Asthagiri-Arunkumar; Denise Jurczyszak; Jose Polanco; Maria Bermudez-Gonzalez; Giulio Kleiner; Teresa Aydillo; Lisa Miorin; Daniel Fierer; Luz Amarilis Lugo; Erna Milunka Kojic; Jonathan Stoever; Sean T.H. Liu; Charlotte Cunningham-Rundles; Philip L. Felgner; Daniel Caplivski; Adolfo Garcia-Sastre; Allen Cheng; Katherine Kedzierska; Olli Vapalahti; Jussi Hepojoki; Viviana Simon; Florian Krammer; Thomas Moran.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20037713

Documentos relacionados

  1. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
  2. Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
  3. Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina.
  4. Antibody tests for identification of current and past infection with SARS-CoV-2.
  5. Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera.
  6. A serological assay to detect SARS-CoV-2 seroconversion in humans.
  7. Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.
  8. Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections.
  9. Long-Term Persistence of Spike Protein Antibody and Predictive Modeling of Antibody Dynamics After Infection With Severe Acute Respiratory Syndrome Coronavirus 2.
  10. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.